To investigate inhibitor selectivity, Compounds N-0130, N-0430 and N-0388 were tested against a small panel of proteases, including matriptase, another TTSP implicated in cancer and viral entry32, as well as potential off-target proteases (FXa, thrombin and furin) (Figure 3, Table S2). Here, FURIN is linked to cancer.